{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:04:15Z","timestamp":1769731455303,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007416","name":"Japan Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ajp.2012.10.007","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T09:45:38Z","timestamp":1354268738000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: Results from a 12-week, flexible dose study using raters masked to antipsychotic choice"],"prefix":"10.1016","volume":"6","author":[{"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tsunoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Chekuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2012.10.007_bib0005","first-page":"CD006633","article-title":"Clozapine versus other atypical antipsychotics for schizophrenia","author":"Asenjo Lobos","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ajp.2012.10.007_bib0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4088\/JCP.09ac05255","article-title":"Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need","volume":"70","author":"Cohen","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","article-title":"Management of treatment resistance in schizophrenia","volume":"50","author":"Conley","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.ajp.2012.10.007_bib0025","first-page":"CD000059","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Essali","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ajp.2012.10.007_bib0030","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/appi.ajp.2011.10060908","article-title":"Effectiveness of switching from antipsychotic polypharmacy to monotherapy","volume":"168","author":"Essock","year":"2011","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0035","first-page":"1","article-title":"A systematic review of the evidence of clozapine's anti-aggressive effects","author":"Frogley","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl. 23","key":"10.1016\/j.ajp.2012.10.007_bib0040","first-page":"39","article-title":"Clozapine: diabetes mellitus, weight gain, and lipid abnormalities","volume":"62","author":"Henderson","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0447.2011.01711.x","article-title":"A user\u2019 guide to clozapine","volume":"123","author":"Kane","year":"2011","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.ajp.2012.10.007_bib0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31887\/DCNS.2010.12.3\/jkane","article-title":"Pharmacologic treatment of schizophrenia","volume":"12","author":"Kane","year":"2010","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.ajp.2012.10.007_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive And Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.ajp.2012.10.007_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.ajp.2012.10.007_bib0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/archpsyc.1989.01810070098017","article-title":"Duration of a clozapine trial in neuroleptic-resistant schizophrenia","volume":"46","author":"Meltzer","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2014the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.ajp.2012.10.007_bib0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.152.2.183","article-title":"Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment","volume":"152","author":"Meltzer","year":"1995","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.ajp.2012.10.007_bib0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance","volume":"175","author":"Munro","year":"1999","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"key":"10.1016\/j.ajp.2012.10.007_bib0100","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/npp.2010.78","article-title":"Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients","volume":"35","author":"Nielsen","year":"2010","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2012.10.007_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophrenia Research"},{"issue":"June (3)","key":"10.1016\/j.ajp.2012.10.007_bib0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2710.2011.01311.x","article-title":"Delays in psychiatric drug development in Japan","volume":"37","author":"Shimazawa","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.ajp.2012.10.007_bib0115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1345\/aph.1C381","article-title":"Valproic acid-induced neutropenia","volume":"37","author":"Vesta","year":"2003","journal-title":"The Annals of Pharmacotherapy"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:23:12Z","timestamp":1761754992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201812002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1876201812002006"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2012.10.007","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: Results from a 12-week, flexible dose study using raters masked to antipsychotic choice","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2012.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}